LLLT for BCRL: a Randomized, Placebo-controlled Study

NARecruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

October 31, 2025

Conditions
Breast Cancer Lymphedema
Interventions
DEVICE

Large-area low-level laser therapy(Venusure)

The wavelength was 980±15nm, average dose was 10-40nm/cm2 and maximal output was 1000mW. Total treatment duration was 30 min and frequency was 3 sessions/week for 4 weeks; for a total of 12 sessions

DEVICE

Conventional low-level laser therapy

The wavelength was 808 nm and maximal output was 60 mW. Total treatment duration was 30 min and frequency was 3 sessions/week for 4 weeks; for a total of 12 sessions.

Trial Locations (1)

Unknown

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER